spacer
home > > spring 2002 > the importance of market research in patient recruitmen
PUBLICATIONS


The Importance of Market Research in Patient Recruitmen

Patient recruitment and enrolment are destined to become more challenging as the number of clinical studies grows. There are presently an estimated 50,000 to 60,000 ongoing clinical trials in the US alone (1), and there is every reason to expect this figure to increase based on the rise in R&D expenditures; the number of compounds in the pipeline; the growing number of patients per new drug application (NDA); and the more complex and global nature of trials. Growth is likely to be accompanied by a rise in directly competitive clinical trials, with many seeking access to the same investigators. In addition, there are bound to be more studies aimed at testing new compounds in special populations, which will yield a marketing advantage to the innovator if the studies prove successful.

The traditional patient recruitment model has centred around sponsors' reliance on proven investigators who promise to recruit the agreed upon number of patients from their own resources. In the past, this approach was generally successful as there were far fewer trials than there are presently. Today, a sought-after investigator is likely to have already used an in-house patient database to enrol several ongoing competitive trials, so that investigator may have exhausted his or her supply of potentially qualified patients for new trials. This reality is reflected in the fact that 78 per cent of today's clinical trials fail to meet patient enrolment deadlines (2).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Diana Anderson, PhD, President & Chief Executive Officer at Rheumatology Research International

Dr Diana Anderson is President and Chief Executive Officer at Rheumatology Research International, a comprehensive rheumatology provider to the clinical trials industry, based in Dallas, Texas. Diana oversees the clinical trial management services of over 50 affiliated private practice and academic investigator sites across the US and Canada.

She is well published in the area of arthritis and patient recruitment and is the author of two books: 50 Ways to Cope with Arthritis and A Guide to Patient Recruitment: Today's Best Practices and Proven Strategies. She is a Consultant in these areas to the pharmaceutical industry and performs numerous lectures in the areas of SMOs and patient recruitment.

spacer
Dr Diana Anderson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Engineered llama antibodies neutralise Covid-19 virus

Researchers have developed a family of engineered nanobodies which neutralise the SARS-CoV-2 virus, targeting the viral spike protein in a novel way.
More info >>

White Papers

Role of Comparators in Clinical Trial Supply

Clinical Services International

CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement